Phase 1 3 trials
Phase 1
NCT07594548 Sep 2027 → Sep 2030 expected esophageal adenocarcinoma , gastric adenocarcinoma , gastroesophageal junction adenocarcinoma Northwestern University
Not yet recruiting
No outcome recorded
Phase 1
NCT05827614 Mar 2023 → Mar 2026 cervical squamous cell carcinoma , endometrial carcinoma , estrogen-receptor positive breast cancer , head and neck squamous cell carcinoma +7 Boundless Bio, Inc.
Terminated
No outcome recorded
Phase 1
NCT04965818 Sep 2021 → Jun 2023 non-small cell lung carcinoma Taiho Oncology, Inc.
Terminated
No outcome recorded
Phase 1/2 2 trials
Phase 1/2
NCT02813135 Aug 2016 → Feb 2031 expected childhood malignant neoplasm Gustave Roussy, Cancer Campus, Grand Paris
Recruiting
No outcome recorded
Phase 1/2
NCT02052778 Jul 2014 → Oct 2020 breast cancer , cholangiocarcinoma , gastric cancer , primary brain neoplasm +1 Taiho Oncology, Inc.
Completed
No outcome recorded
Phase 2 12 trials
Phase 2
NCT07639528 Dec 2027 → Dec 2030 expected intrahepatic cholangiocarcinoma Northwestern University
Not yet recruiting
No outcome recorded
Phase 2
NCT06722183 Dec 2025 → Mar 2028 expected colorectal cancer Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Recruiting
No outcome recorded
Phase 2
NCT06263153 Dec 2024 → Dec 2026 expected infiltrating bladder urothelial carcinoma Yuanquan Yang
Recruiting
No outcome recorded
Phase 2
NCT05945823 Jul 2023 → Jan 2026 overdue esophageal adenocarcinoma , esophageal squamous cell carcinoma , gastroesophageal cancer , malignant pancreatic neoplasm Taiho Oncology, Inc.
Active not recruiting
No outcome recorded
Phase 2
NCT05727176 Jul 2023 → Dec 2026 expected cholangiocarcinoma Taiho Oncology, Inc.
Recruiting
No outcome recorded
Phase 2
NCT05036681 Sep 2021 → Sep 2024 endometrial carcinoma , metastatic malignant neoplasm M.D. Anderson Cancer Center
Terminated
No outcome recorded
Phase 2
NCT04828486 Aug 2021 → Sep 2024 hepatocellular carcinoma Mayo Clinic
Completed
No outcome recorded
Phase 2
NCT04601857 Jan 2021 → Mar 2024 urothelial carcinoma Taiho Oncology, Inc.
Terminated
No outcome recorded
Phase 2
NCT04189445 Aug 2020 → Nov 2024 gastroesophageal cancer , hematopoietic and lymphoid cell neoplasm Taiho Oncology, Inc.
Terminated
No outcome recorded
Phase 2
NCT04024436 Jan 2020 → May 2023 breast cancer Taiho Oncology, Inc.
Terminated
No outcome recorded
Phase 2
NCT03767075 Dec 2018 → May 2025 overdue neoplasm Vall d'Hebron Institute of Oncology
Recruiting
No outcome recorded
Phase 2
NCT02693535 Mar 2016 → Dec 2027 expected non-Hodgkin lymphoma , plasma cell myeloma American Society of Clinical Oncology
Recruiting
No outcome recorded
Show 2 more trials Phase 2/3 1 trial
Phase 2/3
NCT06506955 Oct 2024 → Apr 2027 expected metastatic neoplasm Taiho Oncology, Inc.
Enrolling by invitation
No outcome recorded
Phase 3 4 trials
Phase 3
NCT07710885 Jun 2026 → Apr 2030 expected biliary tract cancer Taiho Pharmaceutical Co., Ltd.
Recruiting
No outcome recorded
Phase 3
NCT05615818 Jul 2024 → Jun 2027 expected biliary tract neoplasm UNICANCER
Recruiting
No outcome recorded
Phase 3
NCT04093362 Jan 2021 → Apr 2024 cholangiocarcinoma Taiho Oncology, Inc.
Terminated
No outcome recorded
Phase 3
NCT03784014 Oct 2019 → Dec 2023 soft tissue sarcoma French National Institute of Health and Medical Research
Completed
No outcome recorded
Phase not stated 1 trial
— NCT04507503 — cholangiocarcinoma Taiho Oncology, Inc.
Approved for marketing
No outcome recorded